News
Tuesday 31st May 2011 - Use of SNOB reagents published in American Society of Microbiology Journal
The use of SNOB reagents has recently been published in the American Society of Microbiology journal – the Journal of Bacteriology June 2011, p. 2804–2813.
Wang et al, as part of their work to show Moraxella catarrhalis Nitric Oxide Reductase Is Essential for Nitric Oxide Detoxification, demonstrated the utility of SNOB reagents as S-nitrosothiol (SNO) group binding reagents to detect protein S-nitrosylation.
Glythera has granted Tocris Bioscience an exclusive license to supply SNOB reagents and/or kits for use solely as preclinical research compounds. Accordingly, any researchers wishing to obtain authentic SNOB products are invited to visit the Tocris Bioscience website for further information.
Visit our SNOB Technology page for further information.
Tuesday 31st May 2011 - Use of SNOB reagents published in American Society of Microbiology Journal
The use of SNOB reagents has recently been published in the American Society of Microbiology journal – the Journal of Bacteriology June 2011, p. 2804–2813.
Wang et al, as part of their work to show Moraxella catarrhalis Nitric Oxide Reductase Is Essential for Nitric Oxide Detoxification, demonstrated the utility of SNOB reagents as S-nitrosothiol (SNO) group binding reagents to detect protein S-nitrosylation.
Glythera has granted Tocris Bioscience an exclusive license to supply SNOB reagents and/or kits for use solely as preclinical research compounds. Accordingly, any researchers wishing to obtain authentic SNOB products are invited to visit the Tocris Bioscience website for further information.
Visit our SNOB Technology page for further information.
Archive
May 11: Use of SNOB reagents published in American Society of Microbiology Journal.
Oct 10: Glythera achieves key technical and commercial milestones. » Read More
Sept 10: Glythera Ltd and the FDA enter into vaccine research collaboration agreement. » Read More
Aug 10: Glythera and PATH sign collaboration agreement to evaluate new conjugation technology for pneumococcal vaccines. » Read More
May 09: Glythera advances key technologies in therapeutic protein engineering. » Read More
May 11: Use of SNOB reagents published in American Society of Microbiology Journal.
Oct 10: Glythera achieves key technical and commercial milestones. » Read More
Sept 10: Glythera Ltd and the FDA enter into vaccine research collaboration agreement. » Read More
Aug 10: Glythera and PATH sign collaboration agreement to evaluate new conjugation technology for pneumococcal vaccines. » Read More
May 09: Glythera advances key technologies in therapeutic protein engineering. » Read More